Stocks
MetLife Financial Statements (MET) |
||||||||||
| MetLifesmart-lab.ru | % | 2020 | 2021 | 2022 | 2022 | 2023 | LTM ? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 19.02.2021 | 18.02.2022 | 31.12.2022 | 23.02.2023 | 16.02.2024 | 01.11.2024 | ||||
| Currency | USD | USD | USD | USD | USD | USD | ||||
| Financial report URL | ||||||||||
| Revenue, bln rub | ? | 67 842 | 71 080 | 69 898 | 69 898 | 66 901 | 71 348 | |||
| Operating Income, bln rub | 5 067 | 5 486 | 0.000 | 3 105 | 66 901 | 18 474 | ||||
| EBITDA, bln rub | ? | 8 459 | 10 132 | 3 778 | 7 975 | 3 925 | 830.0 | |||
| Net profit, bln rub | ? | 5 407 | 6 855 | 2 539 | 2 354 | 1 578 | 3 762 | |||
| OCF, bln rub | ? | 11 639 | 12 596 | 4 428 | 13 204 | 13 721 | 15 169 | |||
| CAPEX, bln rub | ? | 4 269 | 4 360 | 0.000 | 0.000 | 1 170 | 383.0 | |||
| FCF, bln rub | ? | 7 370 | 16 956 | 4 428 | 13 204 | 13 721 | 14 786 | |||
| Dividend payout, bln rub | 1 859 | 1 842 | 5 168 | 1 783 | 1 764 | 1 985 | ||||
| Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||||
| Dividend payout ratio, % | 34.4% | 26.9% | 203.5% | 75.7% | 111.8% | 52.8% | ||||
| OPEX, bln rub | 62 775 | 65 594 | 0.000 | 67 039 | 66 407 | 27 102 | ||||
| Cost of production, bln rub | 0.000 | 0.000 | 0.000 | 0.000 | 494.0 | 0.000 | ||||
| R&D, bln rub | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | ||||
| Interest expenses, bln rub | 913.0 | 920.0 | 938.0 | 938.0 | 1 045 | 1 047 | ||||
| Assets, bln rub | 795 146 | 759 708 | 666 611 | 666 611 | 687 584 | 704 976 | ||||
| Net Assets, bln rub | ? | 74 558 | 67 482 | 27 040 | 27 040 | 30 015 | 30 885 | |||
| Debt, bln rub | 18 149 | 17 430 | 17 980 | 17 980 | 18 828 | 15 682 | ||||
| Cash, bln rub | 378 508 | 367 497 | 301 910 | 301 910 | 302 051 | 315 544 | ||||
| Net debt, bln rub | -360 359 | -350 067 | -283 930 | -283 930 | -283 223 | -299 862 | ||||
| Ordinary share price, rub | 47.0 | 62.5 | 72.4 | 72.4 | 66.1 | 60.0 | ||||
| Number of ordinary shares, mln | 907.8 | 862.7 | 779.1 | 803.2 | 762.4 | 699.3 | ||||
| Market cap, bln rub | 42 621 | 53 910 | 56 383 | 58 128 | 50 420 | 41 965 | ||||
| EV, bln rub | ? | -317 738 | -296 157 | -227 547 | -225 802 | -232 803 | -257 897 | |||
| Book value, bln rub | 45 758 | 39 614 | 17 743 | -7 716 | 20 779 | 21 730 | ||||
| EPS, rub | ? | 5.96 | 7.95 | 3.26 | 2.93 | 2.07 | 5.38 | |||
| FCF/share, rub | 8.12 | 19.7 | 5.68 | 16.4 | 18.0 | 21.1 | ||||
| BV/share, rub | 50.4 | 45.9 | 22.8 | -9.61 | 27.3 | 31.1 | ||||
| EBITDA margin, % | ? | 12.5% | 14.3% | 5.41% | 11.4% | 5.87% | 1.16% | |||
| Net margin, % | ? | 7.97% | 9.64% | 3.63% | 3.37% | 2.36% | 5.27% | |||
| FCF yield, % | ? | 17.3% | 31.5% | 7.85% | 22.7% | 27.2% | 35.2% | |||
| ROE, % | ? | 7.25% | 10.2% | 9.39% | 8.71% | 5.26% | 12.2% | |||
| ROA, % | ? | 0.68% | 0.90% | 0.38% | 0.35% | 0.23% | 0.53% | |||
| P/E | ? | 7.88 | 7.86 | 22.2 | 24.7 | 32.0 | 11.2 | |||
| P/FCF | 5.78 | 3.18 | 12.7 | 4.40 | 3.67 | 2.84 | ||||
| P/S | ? | 0.63 | 0.76 | 0.81 | 0.83 | 0.75 | 0.59 | |||
| P/BV | ? | 0.93 | 1.36 | 3.18 | -7.53 | 2.43 | 1.93 | |||
| EV/EBITDA | ? | -37.6 | -29.2 | -60.2 | -28.3 | -59.3 | -310.7 | |||
| Debt/EBITDA | -42.6 | -34.6 | -75.2 | -35.6 | -72.2 | -361.3 | ||||
| R&D/CAPEX, % | 0.00% | 0.00% | 0.00% | 0 | ||||||
| CAPEX/Revenue, % | 6.29% | 6.13% | 0.00% | 0.00% | 1.75% | 0.54% | ||||
| MetLife shareholders | ||||||||||
